#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    ABO haemolytic disease of newborn Metastases to central nervous system Autoimmune demyelinating disease Emphysema Chordoma Pancreatic carcinoma Dementia with Lewy bodies Congenital nephrogenic diabetes insipidus Transitional cell cancer of the renal pelvis and ureter Malignant neoplasm of choroid Pulmonary sarcoidosis Retinal dystrophy Advanced systemic mastocytosis Desmoplastic small round cell tumour Cataract More trials…

    Learn about Rare Diseases

    Medulloblastoma recurrent Wolfram syndrome – Life with Disease Ornithine transcarbamoylase deficiency – Treatment Extranodal marginal zone B-cell lymphoma (MALT type) – Trials in Disease Gaucher’s disease type I Angiosarcoma Systemic sclerosis pulmonary – Diagnostics Hyperoxaluria – Diagnostics Splenic marginal zone lymphoma – Trials in Disease Kearns-Sayre syndrome – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Apixaban Oxybuprocaine Hydrochloride Amikacin Sulfate Estradiol Propranolol Hydrochloride [18F]Alf-Nota-Octreotide Laronidase Methionine PHENTOLAMINE MESILATE Bio89-100 Gsk4527226 DAPIGLUTIDE Adezunap Soya Oil Terbinafine Hydrochloride Doxazosin Mesilate Asp1570 Citric Acid Dc-806 AMMONIUM (15N) CHLORIDE More therapies…

    Learn about Your Condition

    Loeys-Dietz syndrome Dermatomyositis Vitamin D deficiency Thyroid cancer Lupus nephritis Bacterial infection Vascular calcification Ear discomfort Hepato-lenticular degeneration Haematological malignancy Glioblastoma multiforme Infantile spasms Radius fracture Methylmalonic acidaemia Skin angiosarcoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Schizophrenia

  • Study on the Effectiveness of Aripiprazole and Paliperidone in Patients Experiencing Their First Episode of Schizophrenia

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Schizophrenia
    Investigated Drugs:
    • Aripiprazole
    • Risperidone
    Spain

  • Study on the Effects of Vortioxetine on Cognitive Function in Patients with Early Schizophrenia

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Schizophrenia
    Investigated Drugs:
    • Vortioxetine Hydrobromide
    • Chlorpromazine Hydrochloride
    • Haloperidol Decanoate
    Spain

  • Study on Clemastine and Aerobic Exercise for Improving Cognitive Function in Schizophrenia Patients

    Recruiting

    2 1 1
    Investigated Diseases:
    • Schizophrenia
    Investigated Drugs:
    • Clemastine
    • Placebo
    Germany

  • Study on the Effect of Clozapine and Drug Combination for Patients with Schizophrenia Experiencing First-Line Treatment Failure

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Amisulpride
    • Brexpiprazole
    • Cariprazine
    Austria Germany Italy Spain

  • Study on Vafidemstat for Treating Negative Symptoms and Cognitive Impairment in Adults with Schizophrenia

    Recruiting

    2 1
    Investigated Drugs:
    • Vafidemstat
    Bulgaria Poland Romania Slovakia Spain

  • Study on Biomarkers for Predicting Response to Clozapine in Patients with Schizophrenia

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Schizophrenia
    Investigated Drugs:
    • Clozapine
    Denmark
Previous Page
1 2 3 4 5 … 7
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!